Pharmacist teamwork boosts pneumonia vaccine rates in hospitals
NCT ID NCT05060146
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a structured collaboration between pharmacists and doctors could improve pneumococcal vaccination rates in patients at high risk for infection. Over 600 hospitalized adults with chronic conditions or weakened immune systems took part. The pharmacist reviewed medications, educated patients, and coordinated vaccination after discharge.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pneumococcal vaccine
- What this could lead to
- If successful, this approach could significantly increase vaccination rates in at-risk patients, reducing serious infections like pneumonia and meningitis.
- What could go wrong
- This is a completed study, so results are available. However, the intervention relies on multiple steps (pharmacist, doctor, nurse) which may not work in all hospitals or countries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STREPTOCOCCUS PNEUMONIAE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Alès Cévennes
Alès, France
-
CH Comminges Pyrénées
Saint-Gaudens, France
-
CH de Bagnols sur Cèze
Bagnols-sur-Cèze, France
-
CH de Montauban
Montauban, France
-
CH de Perpignan
Perpignan, France
-
CH du Bassin de Thau
Sète, France
-
CHU de Montpellier
Montpellier, France
-
CHU de Nimes
Nîmes, France
-
CHU de Toulouse
Toulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.